1. 1564PDMagnitude of clinical benefit of trials supporting US Food and Drug Administration (FDA) approval of breakthrough and non-breakthrough drugs. (23rd October 2018) Authors: Molto Valiente, C; Borrell, M; Hwang, T; Gich Saladich, I; Barnadas, A; Amir, E; Kesselheim, A; Tibau, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1562PDMagnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA). (23rd October 2018) Authors: Molto Valiente, C; Borrell, M; Ocana Fernandez, A; Templeton, A J; del Carpio, L P; Del Paggio, J; Barnadas, A; Booth, C M; Tibau, A; Amir, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 388PImpaired survival in resected glioblastoma multiforme patients treated with early chemoradiation. (23rd October 2018) Authors: del Carpio, L P; Gomila, P; Camacho, S D; Moron, S; Riudavets, M; Molto, C; Bujosa, A; Borrell, M; Teres, R; Martin, B; Gallardo, P; Acosta, E; Tilea, L; Soto, A; De Quintana, C; Craven-Bartle, J; Gallardo, A; Gomez, B; Bonilla, S; Gallego, O Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗